Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Cancer Research

• Publication date

  1996-01-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8542597
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Photodynamic Therapy of Brain Tumors

  1996cited by this paper
• Heterogeneous response to the growth factors [EGF, PDGF (bb), TGF‐α, bFGF, IL‐2] on glioma spheroid growth, migration and invasion

  1994cited by this paper
• Hypoxia regulatory elements of the human vascular endothelial growth factor gene.

  1994cited by this paper
• Evaluation of a morpholinothiolporphyrin for use in photodynamic therapy.

  1994cited by this paper
• Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant

  1994cited by this paper
• Genomic sequencing.

  1993cited by this paper
• Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract.

  1993cited by this paper
• High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis.

  1993cited by this paper
• Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

  1993cited by this paper
• NYK/FLK-1: a putative receptor protein tyrosine kinase isolated from E10 embryonic neuroepithelium is expressed in endothelial cells of the developing embryo.

  1993cited by this paper
• Transcriptional patterns of growth factors and proto-oncogenes in human glioblastomas and normal glial cells.

  1992cited by this paper
• Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo

  1992cited by this paper
• Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation.

  1992cited by this paper
• The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor.

  1992cited by this paper
• Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

  1992cited by this paper
• Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor.

  1992cited by this paper
• The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA.

  1991cited by this paper
• pEF-BOS, a powerful mammalian expression vector.

  1990cited by this paper
• Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor.

  1990cited by this paper
• Vascular endothelial growth factor: a new member of the platelet-derived growth factor gene family.

  1989cited by this paper
• Vascular permeability factor, an endothelial cell mitogen related to PDGF.

  1989cited by this paper
• Vascular endothelial growth factor is a secreted angiogenic mitogen.

  1989cited by this paper
• Development of a xenograft glioma model in mouse brain.

  1986cited by this paper
• Genomic sequencing.

  1984cited by this paper
• "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

  1984cited by this paper
• Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

  1979cited by this paper
• Transformation of rat cells by DNA of human adenovirus 5.

  1973cited by this paper
• Anti‐Angiogenesis: New Concept for Therapy of Solid Tumors

  1972cited by this paper
• Tumor angiogenesis: a quantitative method for histologic grading.

  1972cited by this paper

• Enzyme-Triggered Chemodynamic Therapy via a Peptide-H2 S Donor Conjugate with Complexed Fe2.

  2023cites this paper
• In vivo C6 glioma models: an update and a guide toward a more effective preclinical evaluation of potential anti-glioblastoma drugs

  2023cites this paper
• Therapeutic and nutraceutical potentials of a brown seaweed Sargassum fusiforme

  2020cites this paper
• Physiological electric field works via the VEGF receptor to stimulate neovessel formation of vascular endothelial cells in a 3D environment

  2018cites this paper
• Effect of a Small Physiological Electric Field on Angiogenic Activity in First-Trimester Extravillous Trophoblast Cells

  2018cites this paper
• Kobe University Repository : Kernel specific kinase inhibitor inhibited the growth of GS-9L glioma in rat brain and prolonged the survival

  2017cites this paper
• Gonadotropin and tumorigenesis: Direct and indirect effects on inflammatory and immunosuppressive mediators and invasion

  2017cites this paper
• Gene therapy in the treatment of human cancer

  2017cites this paper
• Flavonoids as a scaffold for development of novel anti-angiogenic agents: An experimental and computational enquiry.

  2015cites this paper
• TTAC-0001, a human monoclonal antibody targeting VEGFR-2/KDR, blocks tumor angiogenesis

  2015cites this paper
• FoxO3a represses lymphangiogenesis in gastric cancer

  2015cites this paper
• Angiogenesis in Brain Tumors

  2013cites this paper
• Vascular Endothelial Growth Factor in Malignant Disease of the Central Nervous System

  2013cites this paper
• Decreased Growth of Neurogenic Sarcomas Vascular Endothelial Growth Factor Receptor 2 Leads to Inhibition of Angiogenesis by Blocking Activation of the

  2013cites this paper
• Vegfrecine, an inhibitor of VEGF receptor tyrosine kinases isolated from the culture broth of Streptomyces sp.

  2013cites this paper
• Mechanisms, indications and results of salvage systemic therapy for sporadic and von Hippel-Lindau related hemangioblastomas of the central nervous system.

  2013cites this paper
• The biology of brain metastasis.

  2013cites this paper
• Crocetin, a carotenoid derivative, inhibits VEGF-induced angiogenesis via suppression of p38 phosphorylation.

  2012cites this paper
• CNS Penetration of Tyrosine Kinase Inhibitors in Mouse Models

  2012cites this paper
• Production and Purification of Recombinant Human Vascular Endothelial Growth Factor D

  2012cites this paper
• Angiogenesis in neurological disorders: a review

  2012cites this paper
• Purple Rice (Oryza sativa L.) Extract and its Constituents Inhibit VEGF‐induced Angiogenesis

  2012cites this paper
• Inhibition of Breast Cancer Angiogenesis and Metastasis ay Targeting Hypoxia-Inducible Factor-1α

  2012cites this paper
• Bevacizumab Has Differential and Dose-Dependent Effects on Glioma Blood Vessels and Tumor Cells

  2011cites this paper
• Role of tumor vascular architecture in drug delivery.

  2011cites this paper
• REGULATORY FUNCTIONS OF NOTCH SIGNALING IN EARLY EMBRYONIC VASCULAR DIFFERENTIATION AND VESSEL REMODELING

  2011cites this paper
• LYVE-1 enhances the adhesion of HS-578T cells to COS-7 cells via hyaluronan.

  2011cites this paper
• Future Prospects and Challenges of Antiangiogenic Cancer Gene Therapy

  2010cites this paper
• Angiogenesis signaling pathways as targets in cancer therapy

  2010cites this paper
• The expressions of carbonic anhydrase 9 and vascular endothelial growth factor in astrocytic tumors predict a poor prognosis.

  2010cites this paper
• Circulating endothelial progenitor cells in malignant gliomas.

  2010cites this paper
• Angiogenesis inhibition in cancer therapy: platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) and their receptors: biological functions and role in malignancy.

  2010cites this paper
• Brain Tumor Therapy with Antisense Oligonucleotides

  2009cites this paper
• Solid lipid nanoparticles for brain tumors therapy

  2009cites this paper
• Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor

  2009cites this paper
• Chapter 11 - Solid lipid nanoparticles for brain tumors therapy: State of the art and novel challenges.

  2009cites this paper
• Tumor microvasculature and microenvironment: Therapeutic targets for inhibition of tumor angiogenesis and metastasis

  2009cites this paper
• 1 Brain Tumor Angiogenesis

  2009cites this paper
• Targeted therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in tumor-bearing nude mice

  2008cites this paper
• Successful inhibition of intracranial human glioblastoma multiforme xenograft growth via systemic adenoviral delivery of soluble endostatin and soluble vascular endothelial growth factor receptor-2: laboratory investigation.

  2008cites this paper
• Phosphatidylinositol inhibits vascular endothelial growth factor-A--induced migration of human umbilical vein endothelial cells.

  2008cites this paper
• Gene Delivery of the Murine Equivalent of Bevacizumab (Avastin), an Anti-Vascular Endothelial Growth Factor Monoclonal Antibody, to Suppress Growth of Human Tumors in Immunodeficient Mice

  2008cites this paper
• The Emerging Role of Anti-Angiogenic Therapy for Malignant Glioma†

  2008cites this paper
• Heparin affin regulatory peptide/pleiotrophin negatively affects diverse biological activities in C6 glioma cells.

  2008cites this paper
• Vascular endothelial growth factor (VEGF) inhibition--a critical review.

  2007cites this paper
• Novel therapies for malignant gliomas.

  2007cites this paper
• Oncogene addiction: setting the stage for molecularly targeted cancer therapy.

  2007cites this paper
• A critical role of vascular endothelial growth factor D in zebrafish embryonic vasculogenesis and angiogenesis.

  2007cites this paper
• Experimental therapeutic approaches to peripheral nerve tumors.

  2007cites this paper
• Angiogenesis and Anti-Angiogenesis in Brain Tumors

  2007cites this paper
• Pigment epithelium-derived factor inhibits glioma cell growth in vitro and in vivo.

  2007cites this paper
• Philinopside E, a New Sulfated Saponin from Sea Cucumber, Blocks the Interaction between Kinase Insert Domain-Containing Receptor (KDR) and αvβ3 Integrin via Binding to the Extracellular Domain of KDR

  2007cites this paper
• Role of heparanase and heparanase-degraded heparan sulfate in brain-metastatic melanoma

  2007cites this paper
• Prognostic significance of HIF-2alpha/EPAS1 expression in hepatocellular carcinoma.

  2007cites this paper
• Molecular markers of extracellular matrix remodeling in glioblastoma vessels: Microarray study of laser‐captured glioblastoma vessels

  2007cites this paper
• AVALIAÇÃO DO POTENCIAL METASTÁTICO E DA VASCULARIZAÇÃO NAS NEOPLASIAS EPITELIAIS DE GLÂNDULAS SALIVARES

  2007cites this paper
• Prognostic significance of HIF-2α/EPAS1 expression in hepatocellular carcinoma

  2007cites this paper
• Vascular endothelial growth factor and vascular endothelial growth factor receptor inhibitors as anti-angiogenic agents in cancer therapy.

  2007cites this paper
• Philinopside E, a New Sulfated Saponin from Sea Cucumber, Blocks the Interaction between KDR and αvβ3 Integrin via Binding to the Extracellular Domain of KDR

  2007cites this paper
• Insulin-like growth factor type I biology and targeting in malignant gliomas.

  2007cites this paper
• Blockade of the vascular endothelial growth factor-receptor 2 pathway inhibits the growth of human renal cell carcinoma, RBM1-IT4, in the kidney but not in the bone of nude mice.

  2007cites this paper
• Melanoma Intracerebral Xenografts Flow , Fluorodeoxyglucose Uptake , and Proliferation of Human Angiogenesis , Vascular Permeability , Blood Volume , Blood Endothelial Growth Factor Gene Expression : Effects on Tumor Growth Modulation by Sense and Antisense Vascular Updated

  2006cites this paper
• Novel Gene Therapeutic Approaches to Brain Cancer

  2006cites this paper
• Gene expression property of high-density three-dimensional tissue of HepG2 cells formed in radial-flow bioreactor.

  2006cites this paper
• Activation of p38 MAPK and/or JNK contributes to increased levels of VEGF secretion in human malignant glioma cells.

  2006cites this paper
• in Vivo of Many Tumor Types Dominant-Negative Inhibition of Flk-1 Suppresses the Growth Updated Version

  2006cites this paper
• Adenovirus-Mediated HSV-tk Gene Therapy for Malignant Glioma: Clinical Experience

  2006cites this paper
• Cells Growth of Human Breast Carcinoma in Vivo not Continued Vascular Endothelial Growth Factor Is Essential for Initial but Updated

  2006cites this paper
• Molecular therapies for malignant glioma

  2006cites this paper
• Advances in Brief Vascular Endothelial Growth Factor Is a Predictor of Relapse and Stage Progression in Superficial Bladder Cancer '

  2006cites this paper
• Immunohistochemical Expression of Prostate-specific Membrane Antigen in Uveal Melanoma

  2006cites this paper
• endothelial growth factor in eye disease Role of vascular permeability factor/vascular

  2006cites this paper
• Angiogenesis in malignant glioma--a target for antitumor therapy?

  2006cites this paper
• Vascular Targeting and Therapeutics for Squamous Cell Carcinoma of the Head and Neck

  2006cites this paper
• Resveratrol Suppresses the Angiogenesis and Tumor Growth of Gliomas in Rats

  2005cites this paper
• Angiogenesis and radiation response modulation after vascular endothelial growth factor receptor-2 (VEGFR2) blockade.

  2005cites this paper
• The evolution of cancer research and drug discovery at Lilly Research Laboratories.

  2005cites this paper
• Dynamics of vascular normalization during anti-angiogenic therapy : implications for combination therapy

  2005cites this paper
• Future therapies for hepatocellular carcinoma.

  2005cites this paper
• Gene therapy and targeted toxins for glioma.

  2005cites this paper
• [Angiogenesis and anti-angiogenic strategies for glioblastoma].

  2005cites this paper
• Inhibition of experimental U-118MG glioblastoma by targeted cytotoxic analogs of bombesin and somatostatin is associated with a suppression of angiogenic and antiapoptotic mechanisms.

  2005cites this paper
• Antiangiogenic therapy of head and neck squamous cell carcinoma by vascular endothelial growth factor antisense therapy.

  2005cites this paper
• Gene therapy and targeted toxins for glioma.

  2005cites this paper
• Transfer of the sFLT-1 Gene in Morris Hepatoma Results in Decreased Growth and Perfusion and Induction of Genes Associated with Stress Response

  2005cites this paper
• Herpes Simplex Virus Amplicon Delivery of a Hypoxia-Inducible Soluble Vascular Endothelial Growth Factor Receptor (sFlk-1) Inhibits Angiogenesis and Tumor Growth in Pancreatic Adenocarcinoma

  2005cites this paper
• Angiogenesis pathway inhibitors.

  2005cites this paper
• Angiogenesis and cerebral neoplasia.

  2005cites this paper
• Inhibiting Cancer Angiogenesis With Molecular Therapy

  2005cites this paper
• Increased pituitary vascular endothelial growth factor-a in dopaminergic D2 receptor knockout female mice.

  2005cites this paper
• Ovarian cancer gene therapy

  2005cites this paper
• An Anti-VEGF Ribozyme Embedded within the Adenoviral VAI Sequence Inhibits Glioblastoma Cell Angiogenic Potential in vitro

  2004cites this paper
• Resistance to anti-VEGF agents.

  2004cites this paper
• Vascular endothelial growth factor: basic science and clinical progress.

  2004cites this paper
• Herpes simplex virus amplicon delivery of a hypoxia-inducible angiogenic inhibitor blocks capillary formation in hepatocellular carcinoma

  2004cites this paper
• Resveratrol Suppresses the Angiogenesis and Tumor Growth of Gliomas in Rats

  2004cites this paper
• Treatment of experimental breast cancer using interleukin-12 gene therapy combined with anti-vascular endothelial growth factor receptor-2 antibody.

  2004cites this paper
• Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomas.

  2004cites this paper
• Irradiated C6 glioma cells induce angiogenesis in vivo and activate endothelial cells in vitro

  2004cites this paper
• Anti-angiogenic chemotherapy in central nervous system tumors.

  2004cites this paper